Should methyldibromo glutaronitrile continue to be used in the European baseline Series? A REIDAC national cross‐sectional study

Background Methyldibromo glutaronitrile (MDBGN) was one of the most frequent and relevant allergens found in patch testing at the beginning of this century. In 2008, this preservative was banned from cosmetics in Europe and ever since the prevalence of contact allergy to MDBGN has progressively decr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Contact dermatitis 2021-11, Vol.85 (5), p.572-577
Hauptverfasser:	Mercader‐García, Pedro, Pastor‐Nieto, María Antonia, Gonzalez‐Perez, Ricardo, Cordoba‐Guijarro, Susana, Gimenez‐Arnau, Ana María, Ruiz‐Gonzalez, Inmaculada, Mora‐Fernández, Verónica, Miquel, Javier, Silvestre‐Salvador, Juan Francisco, Ortiz‐Frutos, Francisco Javier, Sanz‐Sanchez, Tatiana, Rodriguez‐Serna, Mercedes, Perez‐Feal, Patricia, Sánchez‐Pérez, Javier, Heras‐Mendaza, Felipe, Serra‐Baldrich, Ester, Zaragoza‐Ninet, Violeta, Hervella‐Garces, Marcos, Gatica‐Ortega, María Elena, García‐Doval, Ignacio, Descalzo, Miguel Ángel, Borrego, Leopoldo
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Allergens allergic contact dermatitis Allergies clinical relevance Cosmetics Cosmetics - adverse effects Cross-Sectional Studies cross‐sectional study Dermatitis, Allergic Contact - epidemiology Eczema Epidemiology Female Humans Male methyldibromo glutaronitrile Middle Aged Nitriles - adverse effects patch tests Patch Tests - statistics & numerical data Patients Preservatives Preservatives, Pharmaceutical - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!